how does tirzepatide help pcos and PCOS: Weight Loss Results and Metabolic Effects – PlexusDx Tirzepatide for PCOS: Insulin Sensitivity

Long-term safety data, dosing guidance for women in perimenopause or menopause, and interaction effects with hormone therapy are still being established through formal research

GLP-1 medications were originally developed to treat type 2 diabetes, but several drugs in this class later received FDA approval for chronic weight management and obesity treatment

These treatments are typically used for type 2 diabetes and weight management

Results at 68 weeks: 40.4% of CagriSema participants lost 25% or more of their body weight 91.9% lost at least 5% Blood pressure fell by 10.9 mmHg systolic on average About 40% of participants reduced or stopped blood pressure medications 87.7% of those with prediabetes at baseline achieved normal blood sugar Results were published in the New England Journal of Medicine and presented at the American Diabetes Associations 2026 Scientific Sessions

The Klow Blend is typically administered via subcutaneous injection, usually in the abdominal area